All News Bioventus Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-16 EDT			5-day change	1st Jan Change
6.63 ^USD	+4.41%		+21.43%	+25.81%

05-07	Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024	CI
05-07	Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024

Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024	05-07	CI
Bioventus : Q1'24 Earnings Call Slides	05-07	PU
Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Bioventus Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	05-07	CI
Earnings Flash (BVS) BIOVENTUS Reports Q1 Revenue $129.5M	05-07	MT
Earnings Flash (BVS) BIOVENTUS Reports Q1 EPS $0.07	05-07	MT
Bioventus Reports First Quarter Financial Results	05-07	AQ
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024	04-29	AQ
Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating	03-13	MT
Bioventus : Q4’23 Earnings Call Slides	03-12	PU
Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024	03-12
Earnings Flash (BVS) BIOVENTUS Posts Q4 Revenue $135.4M	03-12	MT
Earnings Flash (BVS) BIOVENTUS Reports Q4 EPS $0.07	03-12	MT
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	03-12	AQ
Bioventus Inc. Provides Earnings Guidance for the Year 2024	03-12	CI
Bioventus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-12	CI
Bioventus Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-12	CI
North American Morning Briefing : Inflation Data -2-	03-12	DJ
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	03-04	AQ
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	01-18	AQ

No results for this search